Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

75.46
-3.1500-4.01%
Post-market: 76.000.5400+0.72%16:35 EDT
Volume:851.42K
Turnover:64.75M
Market Cap:3.31B
PE:-69.71
High:79.10
Open:78.45
Low:75.03
Close:78.61
52wk High:91.53
52wk Low:53.89
Shares:43.88M
Float Shares:35.64M
Volume Ratio:0.92
T/O Rate:2.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.55
PE(LYR):-47.46

Loading ...

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 02

Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme

Benzinga
·
Jul 02

Tarsus Pharmaceuticals Faces Medicare Copay Allegations From Culper Research; Shares Fall

MT Newswires Live
·
Jul 02

Tarsus Falls After Short Seller Flags Concerns over Eye Drug

Reuters
·
Jul 02

Culper Research announces Tarsus Pharmaceuticals short position

TIPRANKS
·
Jul 02

Culper Research - We are Short Tarsus Pharmaceuticals

THOMSON REUTERS
·
Jul 02

Tarsus Pharmaceuticals Stockholders Approve Governance and Oversight

TIPRANKS
·
Jun 30

Tarsus Pharmaceuticals Holds Annual Shareholder Meeting

Reuters
·
Jun 30

Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54

Reuters
·
Jun 23

Tarsus Pharma Director William J. Link reports $777,809 common share disposal

Reuters
·
Jun 18

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

Reuters
·
Jun 02

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, Md to Board of Directors

THOMSON REUTERS
·
Jun 02

Evaluating Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 02

Tarsus to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 27

Tarsus Pharmaceuticals (TARS) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 27

Assessing Tarsus Pharmaceuticals (TARS) Valuation After New TP-05 Phase 2b Lyme Disease Trial Update

Simply Wall St.
·
May 22

Tarsus Advances TP-05 Lyme Prevention Trial, Setting Up a New Mid-Stage Catalyst for TARS Investors

TIPRANKS
·
May 21

Tarsus and John Cena Partner to Raise Awareness of Demodex Blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

THOMSON REUTERS
·
May 14